Simple new method for effective concentration of 188Re solutions from alumina-based 188W-188Re generator

Journal of Nuclear Medicine

Volumn 41, Issue 7, 2000, Pages 1271-1278

  Guhlke, Stefan ^b   Beets, Arnold L ^b   Oetjen, Katrin ^b   Mirzadeh, Saed ^b   Biersack, Hans J ^b   Knapp Jr , Furn F ^a  

^a OAK RIDGE NATIONAL LABORATORY   (United States)

^b NONE

Author keywords

188Re; 188W 188Re generator; Bolus concentration

Indexed keywords

ACETIC ACID; ALUMINUM OXIDE; PERRHENIC ACID; RHENIUM 188; TUNGSTEN; UNCLASSIFIED DRUG;

ARTICLE; CONCENTRATION RESPONSE; DISSOCIATION; DRUG SYNTHESIS; GENERATOR; PRIORITY JOURNAL; VALIDATION PROCESS;

ALUMINUM OXIDE; RADIOISOTOPES; RADIONUCLIDE GENERATORS; RHENIUM; TUNGSTEN;

EID: 0033912196     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Knapp FF Jr, Mirzadeh S. The continuing important role of radionuclide generator systems for nuclear medicine. Eur J Nucl Med. 1994;21:1151-1165.
2. Knapp FF Jr, Callahan AP, Beets AL, et al. Processing of reactor-produced tungsten-188 for fabrication of clinical-scale alumina-based tungsten-188/rhenium-188 generators. Appl Radiat Isot. 1997;45:1123-1128.
3. Knapp FF Jr, Beets AL, Guhlke S, et al. Availability of rhenium-188 from the alumina-based tungsten-188/rhenium-188 generator for preparation of rhenium-188-labeled radiopharmaceuticals for cancer treatment. Anticancer Res. 1997;17: 1783-1796.
4. Guhlke S, Beets AL, Biersack HJ, et al. Elution of Re-188 from W-188/Re-188 generators with salts of weak acids permits efficient concentration to low volumes using a new tandem cation/anion exchange system [abstract]. J Nucl Med. 1997;38(suppl):125P.
5. Guhlke S, Beets AL, Oetjin K, et al. Convenient concentration of rhenium-188 and technetium-99m eluates from tungsten-188/rhenium-188 or (n,γ)-produced molybdenum-99/technetium-99m generators to high specific volumes. J Label Cmpds Radiopharm 1998;40:294-297.
6. Knapp FF Jr, Beets AL, Mirzadeh S, et al. Use of a new tandem cation/anion exchange system with clinical-scale generators provides high specific volume solutions of technetium-99m and rhenium-188. In: Proceedings of the Symposium on International Trends in Radiopharmaceuticals for Diagnosis and Therapy, Lisbon, Portugal, March 31-April 2, 1998. Vienna, Austria: International Atomic Energy Agency; 1998:419-425. IAEA-TECDOC-1029.
7. Blower PJ. Extending the life of a Tc-99m-generator: a simple and convenient method for concentrating generator eluate for clinical use. Nucl Med Commun. 1993;14:995-997.
8. 188Re]-pentavalent rhenium dimercaptosuccinic acid complex. Nucl Med Commun. 1993;14:197-203.
9. Lederer CM, Shirley VS, eds. Table of Isotopes. 7th ed. New York, NY: Wiley; 1978.
10. Callahan AP, Rice DE, McPherson DW, et al. The use of alumina "Sep Paks" as a simple method for the removal and determination of tungsten-188 breakthrough from tungsten-188/rhenium-188 generators. Appl Radial Isot. 1992;43:801-804.
11. Knapp FF Jr, Lisic EC, Mirzadeh S, inventors. Tungsten-188/carrier-free rhenium-188 perrhenic acid generator system. U.S. patent 5,275,802. January 4, 1994.
12. Knapp FF Jr, Lisic EC, Mirzadeh S, Callahan AP, inventors. Tungsten-188/carrier-free rhenium-188 perrhenic acid generator system. U.S. patent 5,186,913. February 17, 1993.
13. Knapp FF Jr, Guhlke S, Beets AL, et al. Endovascular beta irradiation for prevention of restenosis using solution radioisotopes: pharmacologic and dosimetric properties of rhenium-188 compounds. Cardiovasc Rad Med. 1999;1:1-12.
14. Knapp FF Jr, Beets AL, Guhlke S, et al. Rhenium-188 liquid-filled balloons effectively inhibit restenosis in a swine coronary overstretch model: a simple new method bridging nuclear medicine and interventional cardiology [abstract]. J Nucl Med. 1998;39(suppl):48P.
15. Knapp FF Jr, Guhlke S, Beets AL, et al. Rhenium-188: attractive properties for intravascular brachytherapy for inhibition of restenosis after PTCA [abstract]. J Nucl Cardiol 1997;4:118.
16. Giedd KN, Amols H, Marboe C. et al. Effectiveness of a beta-emitting liquid-filled perfusion balloon to prevent restenosis [abstract]. Circulation. 1997;96:1-220.
17. Knapp FF Jr, Guhlke S, Beets AL, et al. Intraarterial irradiation with rhenium-188 for inhibition of restenosis after PTCA: strategy and evaluation of species for rapid urinary excretion [abstract]. J Nucl Med. 1997;38(suppl):124P.
18. Palmedo H, Guhlke S, Beets AL, et al. Rhenium-188-HEDP for pain palliation of bone metastases: first clinical results [abstract]. Eur J Nucl Med. 1997;24:962.
19. Guhlke S, Palmedo H, Sartor J, et al. Re-188-HEDP for palliative therapy of bone metastases: preparation, radiochemistry and in vivo quality control in mice and rats [abstract]. Nuklearmedizin. 1996;36:A34.
20. Verdera ES, Gaudiano J, Leon A, et al. Rhenium-188-HEDP: kit formulation and quality control. Radiochim Acta. 1997;77:113-118.
21. Maxon HR, Schroder LE, Washburn LC, et al. Rhenium-188 (Sn)HEDP for treatment of osseous metastases. J Nucl Med. 1998;39:659-683.
22. Blower PJ, Lam ASK, O'Doherty MJ, et al. Pentavalent rhenium-188 dimercaptosuccinic acid for targeted radiotherapy: synthesis and preliminary animal and human studies. Eur J Nucl Med. 1998;26:613-621.
23. Pinkert J, Wunderlich G, Franke WG, et al. Rhenium-188-labeled microspheres for intraarterial tumor treatment [abstract]. J Nucl Med. 1998;39(suppl):246P.
24. Jeong JM, Kim YJ, Lee DS, et al. Colloidal rhenium-188 entrapped Chitosan for radionuclide therapy [abstract]. J Nucl Med. 1998;39(suppl):235P.
25. Lin WY, Chen MN, Wang BT, et al. Biodistribution of rhenium-188 Lipiodol in rats following hepatic arterial injection [abstract]. Eur J Nucl Med. 1995;22:891.
26. Kim YJ, Jeong JM, Kim SK, et al. Rhenium-188-sulfur colloid suspended in Lipiodol: a capillary-blocking radiopharmaceutical for targeting liver cancer [abstract]. J Nucl Med 1998;39(suppl):235P.
27. Wang SJ, Lin WY, Hseih BT, et al. Rhenium-188 sulfur colloid as a radiation synovectomy agent. Eur J Nucl Med. 1995;22:505-507.
28. Griffiths GL, Knapp FF Jr, Callahan AP, et al. Direct radiolabeling of monoclonal antibodies with generator-produced rhenium-188 for radioimmunotherapy. Cancer Res. 1991;51:4594-4602.
29. Griffiths GL, Goldenberg DM, Jones AL, et al. Radiolabeling of monoclonal antibodies and fragments with technetium and rhenium. Bioconjugate Chem. 1992;3:91-99.
30. Hosono MN, Hosono M, Zamora PO, et al. Localization of colorectal carcinoma with rhenium-188-labeled B72.3 antibody in xenographed mice. Ann Nucl Med. 1998;12:83-88.
31. Sikes TR, Somayaji V, Bier S, et al. Radiolabeling of monoclonal antibody B43.13 with rhenium-188 for immunoreactivity. Appl Radiat Isot. 1997;48:899-906.
32. 188Re-RC-160, a somatostatin analogue. Tumor Targeting. 1996;2:49-59.
33. Zamora PO, Marek MJ, Knapp FF Jr. Preparation of Re-188-RC-160 somatostatin analogue: a peptide for regional radiotherapy. Appl Radiat Isot. 1997;48:305-310.
34. 188Re-RC-160, a directly-radiolabeled somatostatin analogue. Int J Cancer. 1996;65:214-220.
35. Ehrhardt GJ, Ketring AR, Liang Q, et al. Refinement of the peroxide process for making W-188/Re-188 and Mo-99/Tc-99m gel radioisotope generators for nuclear medicine. In: Nicolini M, Bandoli G, Mazzi U, eds. Technetium and Rhenium in Chemistry and Nuclear Medicine. Vol 4. Padova, Italy: SG Editoriali; 1995:313-317.
36. Dean JA, ed. Lange's Handbook of Chemistry. 12th ed. New York, NY: McGraw-Hill; 1979.
37. 99mTc generator technology. Int J Appl Radiat Isot. 1982;33:811-819.
38. Kuzina AF, Tagil TS, Zamosanikova NN, et al. Extraction of technetium-99m with acetone. Proc Acad Sci USSR Chem Soc. 1962;142:569-571.